Matthew P. Young
2017
In 2017, Matthew P. Young earned a total compensation of $3.3M as Executive Vice President and CFO at Jazz Pharmaceuticals, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,000 |
|---|---|
| Option Awards | $1,060,658 |
| Salary | $545,385 |
| Stock Awards | $1,361,800 |
| Other | $9,810 |
| Total | $3,292,653 |
Young received $1.4M in stock awards, accounting for 41% of the total pay in 2017.
Young also received $315K in non-equity incentive plan, $1.1M in option awards, $545.4K in salary and $9.8K in other compensation.
Rankings
In 2017, Matthew P. Young's compensation ranked 3,233rd out of 14,666 executives tracked by ExecPay. In other words, Young earned more than 78.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,233 out of 14,666 | 78th |
Division Manufacturing | 1,111 out of 5,768 | 81st |
Major group Chemicals And Allied Products | 307 out of 2,074 | 85th |
Industry group Drugs | 236 out of 1,730 | 86th |
Industry Pharmaceutical Preparations | 186 out of 1,329 | 86th |
Source: SEC filing on June 15, 2018.
Young's colleagues
We found five more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2017.
2017
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2017
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2017
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2017
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2017
Michael Miller
Jazz Pharmaceuticals